Todos Medical Enters into Binding Agreement to Acquire All 3CL Protease Biology-Related Assets and Intellectual Property from NLC PharmaAcquisition Agreement • November 29th, 2021 • Todos Medical Ltd. • Surgical & medical instruments & apparatus
Contract Type FiledNovember 29th, 2021 Company Industry● Company to form majority owned subsidiary, 3CL Sciences, an entity focused on the development of variant-agnostic COVID-19 antivirals such as Tollovir that utilize the 3CL protease related IP
November 29, 2021Acquisition Agreement • November 29th, 2021
Contract Type FiledNovember 29th, 2021Todos Medical Enters into Binding Agreement to Acquire All 3CL Protease Biology-Related Assets and Intellectual Property from NLC Pharma